Dr Carol Ibach Duffy, DO | |
1988 East Rd, Shaftsbury, VT 05262-9778 | |
(484) 624-2771 | |
Not Available |
Full Name | Dr Carol Ibach Duffy |
---|---|
Gender | Female |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 1988 East Rd, Shaftsbury, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366571663 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | OS010240L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Carol Ibach Duffy, DO 1988 East Rd, Shaftsbury, VT 05262-9778 Ph: (484) 624-2771 | Dr Carol Ibach Duffy, DO 1988 East Rd, Shaftsbury, VT 05262-9778 Ph: (484) 624-2771 |
News Archive
The combination of ceftolozane with tazobactam broadens the range of antibiotic therapy in adults with severe infections of the lungs, the urinary tract, the renal pelvis and the abdominal cavity.
IRIN examines the next steps in fighting non-communicable diseases (NCDs), "the leading cause of death worldwide," noting, "The World Health Assembly, the decision-making body of the U.N. World Health Organization (WHO), aims to reduce preventable deaths from [NCDs] like diabetes, heart attacks and strokes, chronic respiratory diseases and cancers, by 25 percent by 2025."
The James J. Peters Veterans Hospital in Bronx, New York, is actively recruiting participants for a phase IIb clinical trial testing NIC5-15, a disease modifying candidate for Alzheimer's disease.
Diatron, a global provider of hematology and clinical chemistry analyzers, will exhibit its new high throughput, 5-part differential hematology analyzer with continuous loading autoloader for the first time at Medica 2019 in Dusseldorf, Germany, 18-21 November.
Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found.
› Verified 9 days ago